TRANSTHYRETIN AMYLOIDOSIS
Clinical trials for TRANSTHYRETIN AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new TRANSTHYRETIN AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for TRANSTHYRETIN AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New algorithm could spot hidden amyloidosis cases
Diagnosis TerminatedThis study aimed to see if a computer algorithm could correctly identify patients with ATTR amyloidosis, a rare disease that affects the heart and nerves, by analyzing medical records. The researchers planned to check how well the algorithm worked by comparing its results to actu…
Matched conditions: TRANSTHYRETIN AMYLOIDOSIS
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Diagnosis
Last updated May 26, 2026 08:32 UTC
-
Heart mystery: do Nerve-Targeting drugs also protect the heart?
Knowledge-focused OngoingThis study looks at 20 adults with hereditary ATTR amyloidosis who have both nerve and early heart problems. They are being treated with patisiran or vutrisiran, drugs known to slow nerve damage. Researchers want to see if these drugs also help the heart by using MRI scans and he…
Matched conditions: TRANSTHYRETIN AMYLOIDOSIS
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 08:33 UTC
-
New study aims to catch a rare heart condition earlier in primary care
Knowledge-focused ENROLLING_BY_INVITATIONThis study is testing a way to find a rare heart condition called cardiac amyloidosis earlier in older adults. Researchers will screen 800 people aged 65 and older who have certain heart or muscle symptoms. The goal is to see if simple blood tests in family medicine clinics can h…
Matched conditions: TRANSTHYRETIN AMYLOIDOSIS
Sponsor: Kotyora Family Medicine Health Management and Education Association • Aim: Knowledge-focused
Last updated May 18, 2026 12:00 UTC